EUVIMEDEUVIMED entdecken
Crossref

HIV vaccine acceptability in seronaive patients in a resource limited setting - a pilot study

Olayinka A Olasode, O Olaogun, BY Oladimeji, BJ Olasode

Sudanese Journal of Dermatology · 2006

DOI: 10.4314/sjd.v3i3.32874 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Sudanese Journal of Dermatology, 2006. Verfasst von Olayinka A Olasode und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Current lifetime antiretroviral regimes are associated with clinically important toxicities, and have several limitations (eg. cost, development of resistance, complications). There is need for an alternative regime that must be acceptable, easy to administer and permanent for the eradication of HIV/AIDS. This creates a necessity for vaccine trials in human subjects.

Objectives

To evaluate the response and acceptability profile of a possible coming HIV vaccine trial and usage among a study population that are not aware of their serostatus.

Methods

Five hundred males and females who were seronaive regarding their HIV status were recruited into the study. An open ended questionnaire was administered before and after counselling to assess the acceptability of the proposed vaccine with and without counselling.

Results

Male:female ratio was one to one. Ninety percent (450 out of 500) said they would not take part in a new HIV vaccine trial but only sixty five percent (325 out 500) reacted negatively after counselling. Sixty eight percent (340 out of 500) said they would partake in the vaccination after a successful trial has been carried out on other human subjects and after counselling, this increased to eighty five percent (425 out of 500). The general attitude to HIV vaccine was that of fear and distrust.

Discussion

Coming HIV vaccine trials and usage is likely to be met with suspicion and distrust in resource limited settings. Certain barriers to acceptability of the vaccines need to be addressed to increase acceptability both to the trials and usage of the vaccine. Successful trial will lead to increased acceptability of usage.Sudanese Journal of Dermatology Vol. 3(3) 2005: 113-118

Zitieren

APA

Olasode, O. A., Olaogun, O., Oladimeji, B., & Olasode, B. (2006). HIV vaccine acceptability in seronaive patients in a resource limited setting - a pilot study. Sudanese Journal of Dermatology. https://doi.org/10.4314/sjd.v3i3.32874

Vancouver

Olasode OA, Olaogun O, Oladimeji B, Olasode B. HIV vaccine acceptability in seronaive patients in a resource limited setting - a pilot study. Sudanese Journal of Dermatology. 2006. doi:10.4314/sjd.v3i3.32874

BibTeX
@article{Olasode2006,
  author = {Olasode, Olayinka A and Olaogun, O and Oladimeji, BY and Olasode, BJ},
  title = {HIV vaccine acceptability in seronaive patients in a resource limited setting - a pilot study},
  journal = {Sudanese Journal of Dermatology},
  year = {2006},
  doi = {10.4314/sjd.v3i3.32874}
}
Kostenlos starten →